Myeloid Lymphoid Neoplasms with Pdgfra Rearrangement
📧 Sign up to get email alerts when something new happens for Myeloid Lymphoid Neoplasms with Pdgfra Rearrangement.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2020-01-09FDA Approved: IMATINIB MESYLATE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for imatinib mesylate from Teva Pharmaceuticals USA, Inc., under ANDA204285.